Clinical Trials Browser

Completed × Melanoma × Monophenol Monooxygenase × Clear all

NCT00084656 2022-04-14

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Phase 2 Completed

77 enrolled 13 charts

Uveal Melanoma, Melanoma

NCT00001685 2008-03-04

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Phase 2 Completed

Melanoma, Neoplasm Metastasis, Neoplasms